Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.57% | 6.65% | 8.81% | 9.64% | 9.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.57% | 6.65% | 8.81% | 9.64% | 9.26% |
| Cost of Revenue | 3.95% | 1.75% | 6.69% | 8.76% | 8.67% |
| Gross Profit | 8.18% | 9.73% | 10.12% | 10.19% | 9.63% |
| SG&A Expenses | 3.96% | 3.62% | 5.87% | 6.55% | 4.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.24% | 3.08% | 6.29% | 7.59% | 6.64% |
| Operating Income | 24.00% | 35.78% | 28.92% | 26.50% | 33.94% |
| Income Before Tax | 20.87% | 29.17% | 19.15% | 32.11% | 35.99% |
| Income Tax Expenses | 22.54% | 35.27% | 25.56% | 32.52% | 39.36% |
| Earnings from Continuing Operations | 20.37% | 27.38% | 17.28% | 31.99% | 35.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -276.58% | -289.31% | -65.53% | -17.00% | 24.04% |
| Net Income | 19.71% | 26.78% | 16.94% | 32.06% | 35.28% |
| EBIT | 24.00% | 35.78% | 28.92% | 26.50% | 33.94% |
| EBITDA | 23.63% | 34.14% | 31.06% | 22.99% | 27.26% |
| EPS Basic | 20.14% | 25.93% | 15.00% | 29.60% | 33.33% |
| Normalized Basic EPS | 20.60% | 27.64% | 16.83% | 29.70% | 34.33% |
| EPS Diluted | 20.14% | 25.93% | 15.00% | 29.60% | 33.33% |
| Normalized Diluted EPS | 20.60% | 27.64% | 16.83% | 29.70% | 34.33% |
| Average Basic Shares Outstanding | -0.43% | 0.47% | 2.30% | 2.31% | 1.76% |
| Average Diluted Shares Outstanding | -0.43% | 0.47% | 2.30% | 2.31% | 1.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |